GSK agrees $3bn fine

GlaxoSmithKline today agreed to one of the largest fines ever levied on a pharmaceuticals firm to settle a trio of long-running disputes with the US government.

The UK drugs giant will pay $3bn (€2.18bn) to end three separate legal cases that stretch back to 1997 and relate to the sales and marketing of nine drugs.